The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free treatment for patients with EGFR-mutated non-small cell lung cancer across all ...

Iran is doing exactly what President Donald Trump warned it not to do — slaughtering political prisoners — even as its rulers ...

Tiffany Le Sueur was charged after being caught with a syringe and cup of feces at the Columbus Nationwide Children's ...

Julia Bradbury shares cannula health update after cancer reflection - Bradbury shared a video from a hospital chair to her 330,000 Instagram followers ...

A single intravenous infusion of adeno-associated virus serotype 9 encoding beta-galactosidase (AAV9-GLB1) was associated with short-lived adverse events, increased beta-galactosidase levels, and ...

For patients with non-large vessel occlusion, acute ischemic stroke and salvageable brain tissue, intravenous tenecteplase ...

Hospital demand for IV solutions in the U.S. is lower than before Hurricane Helene, the company said.

Reports record revenue of $22.7 million for the fourth quarter of 2025, an increase of $3.3 million, or 17%, compared to the same period in ...

The advanced technology was added to all ambulances and quick response vehicles in the county beginning February 1st.

SQ Innovation, Inc. today announced that following its FDA approval in October 2025, Lasix(R) ONYU (furosemide injection) is now available for ordering through Cardinal Health's Specialty ...